These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28329092)

  • 1. Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants.
    Kazi AM; Cortese MM; Yu Y; Lopman B; Morrow AL; Fleming JA; McNeal MM; Steele AD; Parashar UD; Zaidi AKM; Ali A
    J Infect Dis; 2017 Mar; 215(5):786-789. PubMed ID: 28329092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
    Armah GE; Cortese MM; Dennis FE; Yu Y; Morrow AL; McNeal MM; Lewis KDC; Awuni DA; Armachie J; Parashar UD
    J Infect Dis; 2019 Feb; 219(5):746-749. PubMed ID: 30357332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.
    Boniface K; Byars SG; Cowley D; Kirkwood CD; Bines JE
    J Infect Dis; 2020 Mar; 221(7):1070-1078. PubMed ID: 31763671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.
    Pollock L; Bennett A; Jere KC; Dube Q; Mandolo J; Bar-Zeev N; Heyderman RS; Cunliffe NA; Iturriza-Gomara M
    Clin Infect Dis; 2019 Sep; 69(8):1313-1319. PubMed ID: 30561537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.
    Williams FB; Kader A; Colgate ER; Dickson DM; Carmolli M; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Petri WA; Haque R; Qadri F; Kirkpatrick BD; Lee B
    J Infect Dis; 2021 Oct; 224(7):1147-1151. PubMed ID: 32157282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants.
    Burke RM; Payne DC; McNeal M; Conrey SC; Burrell AR; Mattison CP; Casey-Moore MC; Mijatovic-Rustempasic S; Gautam R; Esona MD; Thorman AW; Bowen MD; Parashar UD; Tate JE; Morrow AL; Staat MA
    J Infect Dis; 2024 Sep; 230(3):754-762. PubMed ID: 38330312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants.
    El-Heneidy A; Cheung C; Lambert SB; Wang CYT; Whiley DM; Sly PD; Ware RS; Grimwood K
    Pathology; 2022 Dec; 54(7):928-934. PubMed ID: 35817636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants.
    Bucardo F; Reyes Y; Rönnelid Y; González F; Sharma S; Svensson L; Nordgren J
    Sci Rep; 2019 Jul; 9(1):10764. PubMed ID: 31341254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccination.
    Middleton BF; Danchin M; Cunliffe NA; Jones MA; Boniface K; Kirkwood CD; Gallagher S; Kirkham LA; Granland C; McNeal M; Donato C; Bogdanovic-Sakran N; Handley A; Bines JE; Snelling TL
    Vaccine; 2023 Jun; 41(24):3579-3583. PubMed ID: 37179162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children.
    Bucardo F; Nordgren J; Reyes Y; Gonzalez F; Sharma S; Svensson L
    Sci Rep; 2018 Jan; 8(1):1502. PubMed ID: 29367698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial.
    Ali SA; Kazi AM; Cortese MM; Fleming JA; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi A
    J Infect Dis; 2014 Dec; 210(11):1772-9. PubMed ID: 24939906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
    Lee B; Dickson DM; deCamp AC; Ross Colgate E; Diehl SA; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Taniuchi M; Petri WA; Haque R; Qadri F; Kirkpatrick BD
    J Infect Dis; 2018 Apr; 217(9):1399-1407. PubMed ID: 29390150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.
    Sharma S; Nordgren J
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low fecal rotavirus vaccine virus shedding is significantly associated with non-secretor histo-blood group antigen phenotype among infants in northern Pretoria, South Africa.
    Magwira CA; Kgosana LP; Esona MD; Seheri ML
    Vaccine; 2020 Dec; 38(52):8260-8263. PubMed ID: 33213928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of elevated rotavirus-specific antibody titers with HBGA secretor status in Swedish individuals: The FUT2 gene as a putative susceptibility determinant for infection.
    Günaydın G; Nordgren J; Sharma S; Hammarström L
    Virus Res; 2016 Jan; 211():64-8. PubMed ID: 26454189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
    Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
    Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.
    Donato CM; Handley A; Byars SG; Bogdanovic-Sakran N; Lyons EA; Watts E; Ong DS; Pavlic D; At Thobari J; Satria CD; Nirwati H; Soenarto Y; Bines JE
    J Infect Dis; 2024 Apr; 229(4):1010-1018. PubMed ID: 37592804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histo-Blood Group Antigens in Children with Symptomatic Rotavirus Infection.
    Pérez-Ortín R; Vila-Vicent S; Carmona-Vicente N; Santiso-Bellón C; Rodríguez-Díaz J; Buesa J
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30974776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
    Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
    Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.
    Harris V; Ali A; Fuentes S; Korpela K; Kazi M; Tate J; Parashar U; Wiersinga WJ; Giaquinto C; de Weerth C; de Vos WM
    Gut Microbes; 2018 Mar; 9(2):93-101. PubMed ID: 28891751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.